1. Home
  2. FOSL vs TENX Comparison

FOSL vs TENX Comparison

Compare FOSL & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

HOLD

Current Price

$4.02

Market Cap

265.3M

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$12.01

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOSL
TENX
Founded
1984
1967
Country
United States
United States
Employees
4500
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.3M
317.8M
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
FOSL
TENX
Price
$4.02
$12.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$29.67
AVG Volume (30 Days)
848.6K
647.9K
Earning Date
05-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$5.34
52 Week High
$5.75
$18.38

Technical Indicators

Market Signals
Indicator
FOSL
TENX
Relative Strength Index (RSI) 41.42 43.24
Support Level $3.71 $10.83
Resistance Level $4.23 $14.15
Average True Range (ATR) 0.34 0.70
MACD -0.01 0.06
Stochastic Oscillator 33.86 56.04

Price Performance

Historical Comparison
FOSL
TENX

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: